Detalhe da pesquisa
1.
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19.
Anaerobe
; 80: 102699, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702174